TY  - BOOK
AU  - Roth, Jack (ed)
AU  - Ki Hong, Wau (ed)
AU  - Komaki, Ritsuko (ed)
TI  - Lung Cancer
SN  - 1118468740
PY  - 2014///
CY  - New Jersey
PB  - Wiley
KW  - Lung Cancer
N1  - Smoking prevention and cessation; Lung cancer susceptability and risk assessment models; Molecular profiling; Somatic genome alterations in human lung cancers; Serum proteomic biomarkers; Molecular biology of lung preneoplasia; Detection and treatment of preneoplastic lesions; Pathology of adenocarcinoma; Management of multifocal bronchioloalveloar carcinoma (BAC); Radiology and lung cancer screening; Imaging lung cancer; Staging of the medastinum; Managing of the solitary pulmonary nodule; Minimally invasive resections for lung cancer; Extended resections for lung cancer; Bronchoscopic interventions for liung cancer; Primary tracheal tumors; Adjuvant chemotherapy following surgery for lung cancer; Neoadjuvant chemotherapy following resectle non-small cell lung cancer; Image-guided radiation therapy; Stereotactic ablative radiotherapy for lung cancer; Proton therapy; Combinations of radiation therapy and chemotherapy for non-small cell and small-cell lung cancer; Molecular target treatment for personalizaed radiotherapy in lung cancer; EGFR tyrosine kinase inhibitors and monoclonal antibodies: clinical trial review; Mechanisms to the resistance to epidermal drowth factor receptor (EGFR) in non-small cell lung cancer; Predictive tumor biomarkers for EGFR inhibitors; Immunologic approaches to lung cancer therapy; Novel and emerging agents in NSCLC; Novel clinical trial designs for metastatic lung cancer; Novel statistical models for NSCLC clinical trials; Tumor microenvironment, angiogenesis biology, and targeted therapy; Anti-angiogenic agents in metastatic NSCLC; Targeting ALK rearrangements; Non-small cell lung cancers (NSCLC) and mutations in BRAF; Prognostic and predictive biomarker signatures; Brain metastasis from lung cancer; Index
N2  - Here is the comprehensively revised, updated, and expanded edition of the well–established, evidence–based reference book that deals with the most recent advances in lung cancer prevention, screening, diagnosis, research, and treatment for the clinician. Edited and authored by leading authorities in the field, this Fourth Edition of the highly regarded Lung Cancer is better than ever –featuring nine new chapters along with seven re–formatted ones that are nearly brand new in content and approach. It covers Smoking Prevention and Cessation; Molecular Profiling; Somatic Genome Alterations in Human Lung Cancers; Management of Multi–Focal Bronchioloalveolar Carcinoma (BAC); Primary Tracheal Tumors; Predictive Tumor Biomarkers for EGFR Inhibitors; Non–Small Cell and Small–Cell Lung Carcinoma; and more
ER  -